The Ubisoft booth is shown at the E3 2017 Electronic Entertainment Expo in Los Angeles, California, U.S. June 13, 2017. REUTERS/ Mike Blake
(Reuters) – French video game producer Ubisoft on Wednesday reported fourth-quarter net bookings of 676.7 million euros, below company’s expectations of approximately 698.0 million euros.
Fourth-quarter sales stood at 516.5 million euros ($578.69 million), also missing the company’s target of around 571.0 million euros
“IFRS 15 … was introduced in our books this year,” CFO Frederick Duguet said, referring to accounting rules. “And, as we had announced, we did not restate last year’s figures”, Duguet said on a call.
This means that figures from 2019-2020 can not be compared with the figures from 2018-2019.
The company expects net bookings of around 2.19 billion euros for the full year 2019-2020 and non-IFRS operating income of around 480 million euros.
For the first quarter of the year, the group expects net bookings of around 270.0 million euros.
Reported by Camille Raynaud. Editing by Jane Merriman
more recommended stories
Exclusive: Canada set to postpone Huawei 5G decision to after vote, given sour ties with China – sources
OTTAWA (Reuters) – Canada is likely.
Symantec ends talks to sell to Broadcom over price: sources
(Reuters) – Cybersecurity company Symantec Corp.
U.S., Chinese officials to discuss trade in phone call this week: Mnuchin
U.S. Treasury Secretary Steven Mnuchin gives.
Opioid ‘kingpin’ J&J fueled epidemic, Oklahoma argues at trial’s end
NORMAN, Okla. (Reuters) – Lawyers for.
Oil prices down on dwindling storm impact, Chinese economic data
NEW YORK (Reuters) – Oil prices.
Trump sees slowing Chinese growth pressuring Beijing on trade
WASHINGTON (Reuters) – U.S. President Donald.
Amazon rivals ride on Prime Day marketing as protests unfold
NEW YORK (Reuters) – Amazon.com Inc’s.
China data steadies stocks as U.S. earnings get underway
NEW YORK (Reuters) – A gauge.
Facebook vows Libra currency will wait for approval as U.S. airs worries
WASHINGTON (Reuters) – Facebook Inc said.
Gilead invests $5 billion to deepen ties with biotech Galapagos
(Reuters) – U.S. antiviral drugmaker Gilead.